ALNY AS OF 11/30/2017

Company

ALNYLAM PHARMACEUTICALS, INC.

Filed

December 11, 2017

Accession Number

0000080255-17-001417

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →